T3067 |
Tideglusib
|
865854-05-3
|
98%
|
|
Tideglusib, a non-ATP competitive inhibitor of glycogen synthase kinase 3 (GSK-3), is with anti-inflammatory and neuroprotective activities.
|
T2166 |
TWS119
|
601514-19-6
|
98%
|
|
TWS119 is a GSK-3β inhibitor; capable of inducing neuronal differentiation
|
T14072 |
A-443654
|
552325-16-3
|
98%
|
|
A-443654 is a pan-Akt inhibitor. It has equal potency against Akt1, Akt2, or Akt3 within cells (Ki=160 pM).
|
T60472 |
GSK-3β inhibitor 12
|
784170-07-6
|
98%
|
|
GSK-3β inhibitor 12 is a selective GSK-3β inhibitor.GSK-3β inhibitor 12 inhibits 49.11% of 25 μM GSK-3β activity and 37.11% of 50 μM GSK-3β activity.GSK-3β inhib...
|
T77554 |
4-(2-Bromoacetyl)benzonitrile
|
20099-89-2
|
98%
|
|
4-(2-Bromoacetyl)benzonitrile is a ketone derivative that is used as an intermediate in pharmaceuticals and organic synthesis, and inhibits glycogen synthase kin...
|
T6169 |
Indirubin
|
479-41-4
|
98%
|
|
Indirubin is a potent cyclin-dependent kinases and GSK-3β inhibitor with IC50 of about 5 uM and 0.6 uM.
|
T17019 |
TCS 21311
|
1260181-14-3
|
98%
|
|
TCS 21311 is an effective and highly selective inhibitor of JAK3 (IC50: 8 nM). TCS 21311 inhibits PKCα, PKCθ, and GSK3β (IC50s: 13, 68, and 3 nM, respectively)....
|
T73331 |
GSK3-IN-3
|
331963-27-0
|
98%
|
|
GSK3-IN-3 is a mitochondrial autophagy (mitophagy) inducer and GSK-3 inhibitor (IC50: 3.01 μM) that induces parkin-dependent mitochondrial autophagy. GSK3-IN-3 i...
|
T73270 |
GSK3-IN-2
|
380450-97-5
|
98%
|
|
GSK3-IN-2 is a potent GSK3 inhibitor for the treatment of diabetes and neurodegenerative diseases.
|
T10608 |
BRD5648
|
2056261-42-6
|
98%
|
|
BRD5648 ((R)-BRD0705) is an inactive (R)-enantiomer of BRD0705. BRD0705 is a GSK3α inhibitor (IC50: 66 nM; Kd: 4.8 μM).
|
T2873 |
Ginsenoside Rg2
|
52286-74-5
|
98%
|
|
Ginsenoside Rg2 is one of the major active components of ginseng, act as an NF-κB inhibitor.
|
T6659 |
SB 415286
|
264218-23-7
|
98%
|
|
SB415286 is a potent GSK3α inhibitor with IC50/Ki of 78 nM/31 nM with equally effective inhibition of GSK-3β.
|
T5956 |
VP3.15 dihydrobromide
|
1281681-33-1
|
98%
|
|
VP3.15 dihydrobromide is a potent, orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE7- glycogen synthase kinase (GSK)3 inhibitor(with IC50s of 1....
|
T9987 |
WAY-352753
|
478482-74-5
|
98%
|
|
WAY-352753 is a GSK3B-glycogen synthase kinase-3 beta inhibitor.
|
T11447 |
GNF4877
|
2041073-22-5
|
98%
|
|
GNF4877 is a potent DYRK1A and GSK3β inhibitor (IC50s: 6 nM and 16 nM). It leads to blockade of nuclear factor of activated T-cells (NFATc) nuclear export and in...
|
TN4583 |
Moringin
|
73255-40-0
|
98%
|
|
Moringin is an isothiocyanate obtained from myrosinase-mediated hydrolysis of the glucosinolate precursor glucoMoringin present in Moringa oleifera seeds. Moring...
|
T9611 |
PF-04802367
|
1962178-27-3
|
98%
|
|
PF-04802367 is a highly selective GSK-3 inhibitor with an IC50 of 2.1 nM based on a recombinant human GSK-3β enzyme assay and 1.1 nM based on ADP-Glo assay. It s...
|
T77671 |
GSK3a-IN-38
|
1062138-03-7
|
98%
|
|
GSK3a-IN-38 is a novel small molecule compound that has inhibitory effects on GSK-3a.
|
T9025 |
KY19382
|
2226664-93-1
|
98%
|
|
KY19382 is a potent and orally active dual inhibitor of CXXC5-DVL and GSK3β( IC50s of 19 and 10 nM, respectively). It activates Wnt/β-catenin signaling through i...
|
T69188 |
Aloisine B
|
496864-14-3
|
98%
|
|
Aloisine B inhibited cyclin-dependent kinase and glycogen synthase kinase with IC50 values of 0.85 µM and 0.75 µM, respectively. Aloisine B has antiviral activit...
|